Epstein Secrets

nnual Meeting EFTA_R1_02010989 EFTA02686115 John P. Connolly John Conroy Chief Executive Officer, United Kingdom, Deloitte and Chairman of the Global Board Head, Global Strategic Initiatives Baker & McKenzie United Kingdom USA Jerome Contamine Executive Vice-President and Chief Sanofi-Aventis Fra

cutive Officer Business Editor Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Developme

eneral, World Intellectual Property Organization (WIPO). Geneva Klaus-Peter Gushurst Senior Vice-President, Director of Booz & Company Germany Global Board Antonio Guterres UN High Commissioner for Refugees, Geneva Amy Gutmann President University of Pennsylvania USA Karl-Theodor Freiherr zu Fed

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi

eneral, World Intellectual Property Organization (WIPO). Geneva Klaus-Peter Gushurst Senior Vice-President, Director of Booz & Company Germany Global Board Antonio Guterres UN High Commissioner for Refugees, Geneva Amy Gutmann President University of Pennsylvania USA Karl-Theodor Freiherr zu Fed

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi